Combination Chemotherapy, Radiation Therapy, and Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer

NCT00040794 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

144

Enrollment

NIH

Sponsor class

Conditions

Adenocarcinoma of the Lung
Adenosquamous Cell Lung Cancer
Bronchoalveolar Cell Lung Cancer
Large Cell Lung Cancer
Squamous Cell Lung Cancer
Stage IIIA Non-small Cell Lung Cancer
Stage IIIB Non-small Cell Lung Cancer

Interventions

DRUG: paclitaxel
DRUG: carboplatin
DRUG: gefitinib
RADIATION: radiation therapy
OTHER: laboratory biomarker analysis

Sponsor

National Cancer Institute (NCI)